RYSTIGGO

Product NDC
50474-981
11-digit product format
504740981
Labeler code
50474
Product ID
50474-981_48d5f5c1-c45c-cb63-e063-6394a90a31c8
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
ROZANOLIXIZUMAB
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Labeler
UCB, Inc.
Application
BLA761286
Marketing category
BLA
Marketing start
2024-06-14
Substance
ROZANOLIXIZUMAB
Active strength
140 mg/mL
Pharmacologic classes
Neonatal Fc Receptor Blocker [EPC], Neonatal Fc Receptor Blockers [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
RYSTIGGO
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ROZANOLIXIZUMAB140 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
P7186074QCInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 8 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2642288Internal RxNorm lookup
2642294Internal RxNorm lookup
2685614Internal RxNorm lookup
2685615Internal RxNorm lookup
2685616Internal RxNorm lookup
2685617Internal RxNorm lookup
2685618Internal RxNorm lookup
2685619Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
3c0eb8c2-c042-4954-b451-3baa77f5e6d1Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
27acca31-f9bf-4551-a3a7-821bf95dbf74Product name120231030

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50474-981-83RYSTIGGO3 mL in 1 VIAL, GLASSINJECTION, SOLUTION310
50474-981-83RYSTIGGO1 in 1 CARTONINJECTION, SOLUTION110

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50474-981-83ML - Milliliter50474-981098b33e6-bea8-4d62-876a-b87c812d408e12024-07-12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50474-981RYSTIGGO (ROZANOLIXIZUMAB) INJECTION, SOLUTION [UCB, INC.]5Current NDC, 2 package rows20250508_3c0eb8c2-c042-4954-b451-3baa77f5e6d1.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RYSTIGGOROZANOLIXIZUMABUCB, Inc.3c0eb8c2-c042-4954-b451-3baa77f5e6d12026-01-20Warnings, Adverse reactionsExact identifier
application number: BLA761286
ndc (product): 50474-981

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761286Rystiggorozanolixizumab-noli351(a)Rx2026-06-01

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2642288rozanolixizumab-noli 280 MG in 2 ML InjectionPSN3c0eb8c2-c042-4954-b451-3baa77f5e6d110
2685614rozanolixizumab-noli 420 MG in 3 ML InjectionPSN3c0eb8c2-c042-4954-b451-3baa77f5e6d110
2685616rozanolixizumab-noli 560 MG in 4 ML InjectionPSN3c0eb8c2-c042-4954-b451-3baa77f5e6d110
2685618rozanolixizumab-noli 840 MG in 6 ML InjectionPSN3c0eb8c2-c042-4954-b451-3baa77f5e6d110
2642294RYSTIGGO 280 MG in 2 ML InjectionPSN3c0eb8c2-c042-4954-b451-3baa77f5e6d110
2685615RYSTIGGO 420 MG in 3 ML InjectionPSN3c0eb8c2-c042-4954-b451-3baa77f5e6d110
2685617RYSTIGGO 560 MG in 4 ML InjectionPSN3c0eb8c2-c042-4954-b451-3baa77f5e6d110
2685619RYSTIGGO 840 MG in 6 ML InjectionPSN3c0eb8c2-c042-4954-b451-3baa77f5e6d110
26422942 ML rozanolixizumab-noli 140 MG/ML Injection [Rystiggo]SBD3c0eb8c2-c042-4954-b451-3baa77f5e6d110
26856153 ML rozanolixizumab-noli 140 MG/ML Injection [Rystiggo]SBD3c0eb8c2-c042-4954-b451-3baa77f5e6d110
26856174 ML rozanolixizumab-noli 140 MG/ML Injection [Rystiggo]SBD3c0eb8c2-c042-4954-b451-3baa77f5e6d110
26856196 ML rozanolixizumab-noli 140 MG/ML Injection [Rystiggo]SBD3c0eb8c2-c042-4954-b451-3baa77f5e6d110
26422882 ML rozanolixizumab-noli 140 MG/ML InjectionSCD3c0eb8c2-c042-4954-b451-3baa77f5e6d110
26856143 ML rozanolixizumab-noli 140 MG/ML InjectionSCD3c0eb8c2-c042-4954-b451-3baa77f5e6d110
26856164 ML rozanolixizumab-noli 140 MG/ML InjectionSCD3c0eb8c2-c042-4954-b451-3baa77f5e6d110
26856186 ML rozanolixizumab-noli 140 MG/ML InjectionSCD3c0eb8c2-c042-4954-b451-3baa77f5e6d110
26422942 ML Rystiggo 140 MG/ML InjectionSY3c0eb8c2-c042-4954-b451-3baa77f5e6d110
2642288rozanolixizumab-noli 280 MG per 2 ML InjectionSY3c0eb8c2-c042-4954-b451-3baa77f5e6d110
2685614rozanolixizumab-noli 420 MG per 3 ML InjectionSY3c0eb8c2-c042-4954-b451-3baa77f5e6d110
2685616rozanolixizumab-noli 560 MG per 4 ML InjectionSY3c0eb8c2-c042-4954-b451-3baa77f5e6d110
2685618rozanolixizumab-noli 840 MG per 6 ML InjectionSY3c0eb8c2-c042-4954-b451-3baa77f5e6d110
2642294Rystiggo 280 MG per 2 ML InjectionSY3c0eb8c2-c042-4954-b451-3baa77f5e6d110
2685615Rystiggo 420 MG per 3 ML InjectionSY3c0eb8c2-c042-4954-b451-3baa77f5e6d110
2685617Rystiggo 560 MG per 4 ML InjectionSY3c0eb8c2-c042-4954-b451-3baa77f5e6d110
2685619Rystiggo 840 MG per 6 ML InjectionSY3c0eb8c2-c042-4954-b451-3baa77f5e6d110

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
50474-981-83504740981831 VIAL, GLASS in 1 CARTON (50474-981-83) / 3 mL in 1 VIAL, GLASS2024-07-15NoNoCurrent